A new study from Scripps Research and Calibr-Skaggs scientists provides pharmacological proof of concept for an upcoming phase 1 clinical trial. LA JOLLA, Calif., April 10, 2024 /PRNewswire/ — Pulmonary diseases are a leading cause of morbidity and mortality worldwide. For many…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.